Literature DB >> 16143374

Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trials.

Olga M Shuhatovich1, Mathilde P Sharman, Yvette N Mirabal, Nan R Earle, Michele Follen, Karen Basen-Engquist.   

Abstract

In order to improve recruitment for cervical cancer screening trials, it is necessary to analyze the effectiveness of recruitment strategies used in current trials. A trial to test optical spectroscopy for the diagnosis of cervical neoplasia recruited 1000 women from the community; the trial evaluated the emerging technology against Pap smears and colposcopically directed biopsies for cervical dysplasia. We have examined women's reasons for participating as well as the effectiveness and efficiency for each recruitment strategy. Reasons for participation were identified and compared between trials. The recruitment method that resulted in the most contacts was newspaper reportorial coverage and advertising, followed by family and friends, then television news coverage. The most cost-effective method for finding eligible women who attend the research appointment is word of mouth from a family member or friend. Recommendations are given for maximizing the efficiency of recruitment for cervical cancer screening trials.

Entities:  

Mesh:

Year:  2005        PMID: 16143374     DOI: 10.1016/j.ygyno.2005.07.093

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  9 in total

1.  Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Authors:  Timon P H Buys; Scott B Cantor; Martial Guillaud; Karen Adler-Storthz; Dennis D Cox; Clement Okolo; Oyedunni Arulogon; Oladimeji Oladepo; Karen Basen-Engquist; Eileen Shinn; José-Miguel Yamal; J Robert Beck; Michael E Scheurer; Dirk van Niekerk; Anais Malpica; Jasenka Matisic; Gregg Staerkel; Edward Neely Atkinson; Luc Bidaut; Pierre Lane; J Lou Benedet; Dianne Miller; Tom Ehlen; Roderick Price; Isaac F Adewole; Calum MacAulay; Michele Follen
Journal:  Gend Med       Date:  2011-09-22

2.  Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study.

Authors:  Eileen Shinn; Usman Qazi; Shalini Gera; Joan Brodovsky; Jessica Simpson; Michele Follen; Karen Basen-Engquist; Calum Macaulay
Journal:  Gend Med       Date:  2012-02

3.  Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy.

Authors:  Scott B Cantor; Jose-Miguel Yamal; Martial Guillaud; Dennis D Cox; E Neely Atkinson; John L Benedet; Dianne Miller; Thomas Ehlen; Jasenka Matisic; Dirk van Niekerk; Monique Bertrand; Andrea Milbourne; Helen Rhodes; Anais Malpica; Gregg Staerkel; Shahla Nader-Eftekhari; Karen Adler-Storthz; Michael E Scheurer; Karen Basen-Engquist; Eileen Shinn; Loyd A West; Anne-Therese Vlastos; Xia Tao; J Robert Beck; Calum Macaulay; Michele Follen
Journal:  Int J Cancer       Date:  2010-11-09       Impact factor: 7.396

4.  Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasia.

Authors:  Bryan Pham; Nan Earle; Karen Rabel; Michele Follen; Michael E Scheurer
Journal:  Gynecol Oncol       Date:  2007-09-05       Impact factor: 5.482

5.  Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in Alzheimer disease clinical trials.

Authors:  Sarah A Carr; Roberta Davis; Diane Spencer; Marie Smart; Joanna Hudson; Stephanie Freeman; Greg E Cooper; Fred A Schmitt; William R Markesbery; Deborah Danner; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

6.  Healthy women's motivators and barriers to participation in a breast cancer cohort study: a qualitative study.

Authors:  Pamela S Sinicrope; Christi A Patten; Sarah M Bonnema; Julka R Almquist; Christina M Smith; Timothy J Beebe; Steven J Jacobsen; Celine M Vachon
Journal:  Ann Epidemiol       Date:  2009-03-09       Impact factor: 3.797

7.  Motivation and frustration in cardiology trial participation: the patient perspective.

Authors:  Silmara Meneguin; Luiz Antônio Machado Cesar
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

8.  Motivations for participating in a non-interventional gender-based violence survey in a low-income setting in South Africa.

Authors:  Yandisa Sikweyiya; Mzikazi Nduna; Nwabisa Shai; Rachel Jewkes
Journal:  BMC Public Health       Date:  2017-06-29       Impact factor: 3.295

9.  The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011).

Authors:  Clare Moynihan; Rebecca Lewis; Emma Hall; Emma Jones; Alison Birtle; Robert Huddart
Journal:  Trials       Date:  2012-11-29       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.